Srinivas Tallapragada - Sep 25, 2023 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
Pres/Chief Engineering Officer
Signature
/s/ Sarah Dale, Attorney-in-Fact for Srinivas Tallapragada
Stock symbol
CRM
Transactions as of
Sep 25, 2023
Transactions value $
-$435,649
Form type
4
Date filed
9/26/2023, 04:36 PM
Previous filing
Sep 25, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $1.62M +10K +17.13% $161.50 68.4K Sep 25, 2023 Direct F1
transaction CRM Common Stock Sale -$1.69M -8.26K -12.08% $204.91 60.1K Sep 25, 2023 Direct F1, F2
transaction CRM Common Stock Sale -$358K -1.74K -2.9% $205.81 58.4K Sep 25, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -10K -10.82% $0.00 82.4K Sep 25, 2023 Common Stock 10K $161.50 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2023.
F2 Weighted average price. These shares were sold in multiple transactions at prices ranging from $204.3900 to $205.3400 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $205.4000 to $206.2000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.